Cargando…
Thrombotic Microangiopathy with Severe Proteinuria Induced by Lenvatinib for Radioactive Iodine-Refractory Papillary Thyroid Carcinoma
Standard therapy for radioactive iodine (RAI)-refractory differentiated thyroid cancer (DTC) is multi-targeted kinase inhibitors (m-TKIs), represented by sorafenib and lenvatinib. One of the main target molecules of m-TKIs is vascular endothelial growth factor receptor (VEGF-R). m-TKIs are known to...
Autores principales: | Hyogo, Yasuko, Kiyota, Naomi, Otsuki, Naoki, Goto, Shunsuke, Imamura, Yoshinori, Chayahara, Naoko, Toyoda, Masanori, Nibu, Ken-ichi, Hyodo, Toshiki, Hara, Shigeo, Masuoka, Hiroo, Kasahara, Toshihiko, Ito, Yasuhiro, Miya, Akihiro, Hirokawa, Mitsuyoshi, Miyauchi, Akira, Minami, Hironobu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276762/ https://www.ncbi.nlm.nih.gov/pubmed/30519176 http://dx.doi.org/10.1159/000494080 |
Ejemplares similares
-
Exploratory Analysis to Predict Optimal Tumor Burden for Starting Lenvatinib in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer
por: Suzuki, Chiaki, et al.
Publicado: (2021) -
Thrombotic Microangiopathy, Podocytopathy, and Damage to the Renal Tubules with Severe Proteinuria and Acute Renal Dysfunction Induced by Lenvatinib
por: Nakashima, Saki, et al.
Publicado: (2022) -
Relationship between PDGFR expression and the response to pazopanib in intimal sarcoma of the pulmonary artery: A case report
por: Sai, Satoshi, et al.
Publicado: (2021) -
Metastatic papillary thyroid carcinoma presenting with elevated serum levels of carbohydrate antigen 19-9 (CA19-9): a case report
por: Kihara, Minoru, et al.
Publicado: (2022) -
Lenvatinib for Anaplastic Thyroid Cancer
por: Tahara, Makoto, et al.
Publicado: (2017)